Virios Therapeutics Inc (VIRI)

Virios Therapeutics Inc Azioni (VIRI) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	34.87% 0.0228	0.035	0.0392	0.0363	0.0404
Operating Expenses	15.46% 1.3141	1.1381	1.2743	1.4772	1.5573
Benefits Costs and Expenses	15.46% 1.3141	1.1381	1.2743	1.4772	1.5573
Costs And Expenses	15.46% 1.3141	1.1381	1.2743	1.4772	1.5573
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	15.46% -1.3141	-1.1381	-1.2743	-1.4772	-1.5573
Net Interest Income/Expense	34.87% 0.0228	0.035	0.0392	0.0363	0.0404
Interest Income/Expense After Provision For Losses	34.87% 0.0228	0.035	0.0392	0.0363	0.0404
Income/Loss From Continuing Operations Before Tax	17.06% -1.2913	-1.1032	-1.2351	-1.4409	-1.5169
Income/Loss From Continuing Operations After Tax	17.06% -1.2913	-1.1032	-1.2351	-1.4409	-1.5169
Net Income/Loss	17.06% -1.2913	-1.1032	-1.2351	-1.4409	-1.5169
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	11,777% 19.26	0.1621	19.09	18.41	18.33
Diluted Average Shares	11,777% 19.26	0.1621	19.09	18.41	18.33
Basic Earnings Per Share	40.00% -0.07	-0.05	-0.06	-0.08	-0.08
Diluted Earnings Per Share	40.00% -0.07	-0.05	-0.06	-0.08	-0.08
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-